Evidence map›Paper›PMID 36388419›Full record

ReviewNeuro-oncology practice2022

Surveillance of long-term complications after treatment of adult brain tumor survivors-review and evidence-based recommendations.

Karl Cristie F Figuracion, Lia M Halasz, Ny-Ying Lam, Myron Goldberg, Joe Stuckey, Richard A Failor, Lindsey M Knowles, Samantha Artherholt, Brian Chou, Courtney E Francis and 4 more

Open access · greenAbstract readReview
In one paragraph

Review in Neuro-oncology practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Environmental Enrichment and Health Outcomes Among Low-Grade Glioma Brain Tumor Survivors.The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses · 2024
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Karl Cristie F FiguracionITHS TL1 Training Program University of Washington School of Nursing, Seattle, Washington 98105, USA.ORCID https://orcid.org/0000-0003-1360-5749
Lia M HalaszDepartment of Radiation Oncology, School of Medicine, University of Washington, Seattle, Washington 98105, USA.
Ny-Ying LamDepartment of Rehabilitation Medicine, School of Medicine, University of Washington, Seattle, Washington 98105, USA.
Myron GoldbergDepartment of Rehabilitation Medicine, School of Medicine, University of Washington, Seattle, Washington 98105, USA.
Joe StuckeyDepartment of Rehabilitation Medicine, School of Medicine, 98105 University of Washington, Seattle, Washington 98105, USA.
Richard A FailorDepartment of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, Washington, 98105, USA.
Lindsey M KnowlesDepartment of Rehabilitation Medicine, University of Washington, Seattle, Washington 98105, USA.
Samantha ArtherholtDepartment of Rehabilitation Medicine, University of Washington, Seattle, Washington 98105, USA.
Brian ChouDepartment of Ophthalmology, School of Medicine, University of Washington, Seattle, Washington 98105, USA.
Courtney E FrancisDepartment of Ophthalmology, School of Medicine, University of Washington, Seattle, Washington 98105, USA.
Kristin KnightOregon Health and Science University, Portland, Oregon 97239, USA.
Maninder KaurLoma Linda University Health, Loma Linda, California, USA.
Tatiana SadakBiobehavioral Nursing and Health Informatics, School of Nursing, University of Washington, Seattle, Washington 98105, USA.
Tresa McGranahanDepartment of Neurology, School of Medicine, University of Washington, Seattle, Washington 98105, USA.
University of Washington · USLoma Linda University · USOregon Health & Science University · US

Funding

NRSA Training CoreTL1TR002318 · NCATS · UNIVERSITY OF WASHINGTON · PI Megan Moore · 2017 to 2026
$8.4M
Omics and Symptom Science Training ProgramT32NR016913 · NINR · UNIVERSITY OF WASHINGTON · PI CYNTHIA M DOUGHERTY, Margaret McLean Heitkemper · 2017 to 2026
$3.2M
NCATS NIH HHS TL1 TR002318NINR NIH HHS T32 NR016913
6 · The paper itself

Abstract

As a result of treatment and diagnosis, adults with primary or metastatic brain tumors experience comorbidities that impacts their health and well-being. The Children's Oncology Group has guideline recommendations for childhood survivors of brain tumors; however, guidelines for monitoring long-term sequela among adult brain tumor survivors are lacking. The purpose of this review is to present the screening recommendations for the long-term complications after brain tumor treatment from a multidisciplinary panel of healthcare professionals. Chronic complications identified include cognitive dysfunction, vasculopathy, endocrinopathy, ophthalmic, ototoxicity, physical disability, sleep disturbance, mood disorder, unemployment, financial toxicity, and secondary malignancy. We invited specialists across disciplines to perform a literature search and provide expert recommendations for surveillance for long-term complications for adult brain tumor survivors. The Brain Tumor Center Survivorship Committee recommends routine screening using laboratory testing, subjective assessment of symptoms, and objective evaluations to appropriately monitor the complications of brain tumor treatments. Effective monitoring and treatment should involve collaboration with primary care providers and may require referral to other specialties and support services to provide patient-centered care during neuro-oncology survivorship. Further research is necessary to document the incidence and prevalence of medical complications as well as evaluate the efficacy of screening and neuro-oncology survivorship programs.

Indexed as

adultsbrain tumor survivorshiplong-term complicationsmanagementtoxicity

Identifiers

PMID36388419
PMCPMC9665061
OpenAlexW4283393006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.